Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016

July 25, 2016 By Fink Densford Leave a Comment

Schellhorn out, Emerson in as Monteris CEO Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year. Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year […]

Pages: 1 2 3 4 5 6 7 8

Ex-ConMed exec is Interventional Spine’s new Darling | Personnel Moves

July 8, 2015 By Fink Densford Leave a Comment

Interventional Spine said it has tagged ex-ConMed executive and 25-year medical veteran Joseph Darling as its new vice president and COO. Darling spent 7 years with ConMed, serving as the COO, executive veep and prez of ConMed Linvatec until February this year. Before his time at ConMed, Darling worked with Smith & Nephew, Wyeth-Ayerst Pharmaceuticals, Baxter […]

McKesson dodges Medicare fraud charges

July 11, 2014 By Arezu Sarvestani Leave a Comment

San Francisco-based healthcare giant McKesson (NYSE:MCK) dodged a Medicare fraud lawsuit this week after a federal judge ruled that prospective whistleblower Leslie Ann Williams didn’t have enough evidence to support her accusations.

FDA puts highest-risk label on McKesson’s anesthesia system recall

March 18, 2014 By Arezu Sarvestani Leave a Comment

Updated March 20, 2014, at 3:15 p.m. with comments from McKesson

White House has missed half of ACA deadlines | MassDevice.com On Call

August 20, 2013 By Sony Salzman Leave a Comment

MASSDEVICE ON CALL — During the 1st 3 years of Affordable Care Act implementation, the Obama administration has failed to meet half of its mandatory deadlines, according to a new report from the non-partisan Congressional Research Service.

Study: Abbott, Johnson & Johnson park billions in offshore tax havens

August 5, 2013 By Brad Perriello Leave a Comment

Abbott (NYSE:ABT) parked some $40 billion in 107 overseas tax havens last year, making it 1 of the top 15 U.S. companies with the most money held offshore, according to a U.S. Public Interest Research Group report issued last month.

McKesson to pay $2B for PSS World Medical | Wall Street Beat

October 25, 2012 By MassDevice staff Leave a Comment

McKesson (NYSE:MCK) agreed to pay $29 per share for PSS World Medical (NSDQ:PSSI) and its medical supplies business in a deal worth $2.1 billion.

Abiomed: Medicare coverage decision unlikely for Impella | Wall Street Beat

September 26, 2012 By MassDevice staff Leave a Comment

Abiomed (NSDQ:ABMD) said it doesn’t believe that the Centers for Medicare & Medicaid Services is likely to bestow a national coverage decision for its Impella heart pump.

Supreme Court denies ex-McKesson CEO’s appeal

June 19, 2012 By MassDevice staff Leave a Comment

The Supreme Court refused to review the conviction of former McKesson (NYSE:MCK) chairman & CEO Charles McCall in an accounting scandal, meaning his 10-year prison sentence will stand.

The high court provided no comment on the denial. San Francisco, Calif.-based McKesson is the largest drug distributor in the U.S., and also deals in healthcare information technology products.